Oragenics, Inc. (OGEN)

Last Closing Price: 0.18 (2025-05-12)

Company Description

Oragenics Inc is a biotechnology company focused on the development and licensure of innovative products and technologies for improving human health.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $0.04M
Net Income (Most Recent Fiscal Year) $-10.57M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) --
Price to Book Ratio (Most Recent Quarterly Book Value per Share) --
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) --
Net Margin (Trailing 12 Months) --
Return on Equity (Trailing 12 Months) -3081.71%
Return on Assets (Trailing 12 Months) -330.27%
Current Ratio (Most Recent Fiscal Quarter) 0.87
Quick Ratio (Most Recent Fiscal Quarter) 0.87
Debt to Common Equity (Most Recent Fiscal Quarter) 0.00
Inventory Turnover (Trailing 12 Months) --
Book Value per Share (Most Recent Fiscal Quarter) $-0.02
Earnings per Share (Most Recent Fiscal Quarter) --
Earnings per Share (Most Recent Fiscal Year) --
Diluted Earnings per Share (Trailing 12 Months) $-1.12
Stock
Exchange NYSEMKT
Sector Healthcare
Industry Biotechnology
Common Shares Outstanding 21.48M
Free Float 19.31M
Market Capitalization $3.62M
Average Volume (Last 20 Days) 0.22M
Beta (Past 60 Months) 1.16
Percentage Held By Insiders (Latest Annual Proxy Report) 10.10%
Percentage Held By Institutions (Latest 13F Reports) 18.71%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%